Tri-Coast Pharmacy Recalls L-Carnitine Due to Sterility Concerns
Tri-Coast Pharmacy is recalling 14 vials of L-Carnitine 250 mg/mL because the products lack assurance of sterility. The recall covers sterile products compounded between May 17, 2016, and November 17, 2016.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The source text explicitly identifies the agency classification as Class II. According to the severity rubric, an FDA Class II recall is assigned a score of 4 (Severe).
Plain-English summary
Tri-Coast Pharmacy is recalling 14 vials of L-Carnitine 250 mg/mL (30 mL) due to a lack of assurance of sterility. The recall includes all sterile products compounded by the pharmacy between May 17, 2016, and November 17, 2016. The known lot code is 09132016F, with an expiration date of February 28, 2017.
The products were distributed nationwide. The FDA has classified this recall as Class II, indicating that use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
Consumers who have these products should stop using them and contact Tri-Coast Pharmacy for further instructions or a refund. Healthcare providers should verify the lot code and expiration date of any L-Carnitine 250 mg/mL vials in their inventory to ensure they are not using the recalled product.
The recalled product
- Product
- L-Carnitine 250 mg/mL, (30 ML). Compounded by Tri-Coast Pharmacy
- Manufacturer
- Tri-Coast Pharmacy
- Hazard
- Affected units
- 14
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 80 recalled by Tri-Coast Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 80 products in this recall →Related recalls
Same manufacturer · Tri-Coast Pharmacy
See all →- SevereTri-Coast Pharmacy Recalls TriMix Injection Due to Sterility Concerns
FDA (Drugs) · 2017-01-11
- SevereTri-Coast Pharmacy Recalls Sermorelin Forte Due to Sterility Concerns
FDA (Drugs) · 2017-01-11
- SevereTri-Coast Pharmacy Recalls TriMix Injection Due to Sterility Concerns
FDA (Drugs) · 2017-01-11
- SevereTri-Coast Pharmacy Recalls BiMix Phentolamine/Papaverine Due to Sterility Concerns
FDA (Drugs) · 2017-01-11
- SevereTri-Coast Pharmacy Recalls Quad Mix Sterile Compounded Drug
FDA (Drugs) · 2017-01-11
Same hazard · lack of sterility
See all →- HighRohto Cooling Eye Drops Max Strength Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- HighRohto Cooling Eye Drops Recalled Due to Lack of Assurance of Sterility
FDA (Drugs) · 2026-07-29
- SevereCleviprex Injectable Emulsion Recall Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-07-22
- SeverePemetrexed for Injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-07-15
- SevereAzacitidine for Injection Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2026-07-15